HUTCHINSON, Kan., Aug. 22, 2005 (PRIMEZONE) -- HEE Corporation (Pink Sheets:HCCF), which specializes in nutraceuticals for metabolic syndrome, today announced it will develop, train and deploy national and regional sales representatives within the next thirty days to facilitate the sale of its products and services. The sales representatives will be responsible for nationwide marketing of its breakthrough nutraceuticals HPB-84 and HPB-WL2000 directly to primary care physicians, internists, dieticians, diabetes educators and other medical professionals.
"Since the results of the pilot study were made public, HEE Corp. has received a lot of interest from doctors looking to sell HPB-84 directly to patients," said Radley Brooks, President of HEE Corporation. "The sales force will be able to answer doctor's questions, and ultimately, increase consumer visibility and sales. In the U.S. alone the average family practitioner treats approximately 200 diabetic patients. The quickest and most effective way to reach the medical community will be our national and regional sales representatives."
The sales force will initially consist of 10-12 national sales representatives that will also be responsible for growing sales among retail partners. Regional sales representatives will call on doctors and diabetes treatment centers in key local markets.
"Nationally, there are more than 76,000 Family Physicians, 143,000 Internists, 70,000 Dieticians, 10,000 Diabetes Educators, and 55,000 Chiropractors that could be potential partners," said Brooks.
For more information on HEE Corporation or to purchase its herbal supplement products visit www.hee-corp.com.
About HEE Corporation
Founded in Hutchinson, Kansas in December 2003, HEE Corporation (Pink Sheets:HCCF) is a publicly-traded company committed to improving the quality of life through the research, development and distribution of products, services and nutraceuticals that address many of the causes of metabolic syndrome. Metabolic syndrome is quickly being recognized by the medical community as one of the most prevalent health conditions in the United States. HPB-84, manufactured in the United States, contains a proprietary blend of ingredients generally recognized by the FDA as safe (GRAS). Complete company and investor information can be found at the company Web site, www.hee-corp.com.
Forward-Looking and Cautionary Statements
Statements contained in this release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, as discussed in the company's filings with the Securities and Exchange Commission. HEE Corporation undertakes neither intention nor obligation to publicly update or revise any forward-looking statements. HEE Corporation and the HEE Corporation logo are trademarks or registered trademarks. Copyright 2005. All rights reserved.